Stocks to buy

Teladoc Health (NYSE:TDOC) is among the pandemic-driven high-fliers on a sustained downtrend. At the height of the lockdown, investors piled into companies that would thrive in a stay-at-home and work-at-home scenario. In one year’s time, shares of the virtual healthcare services company rocketed 175% to a high of $308, made in February 2021. Source: fizkes/ShutterStock.com
0 Comments
I have been a big Nvidia (NASDAQ:NVDA) bull for a long time now. All you have to do is look at a chart of NVDA stock over the past five years to see why. The company continues to dominate competitors and there is seemingly nothing to slow it down.  Source: rafapress / Shutterstock.com When NVDA
0 Comments
Investors seeking a potentially explosive play in the growing genomic mapping sector ought to consider Bionano Genomics (NASDAQ:BNGO) stock.  Source: Connect world / Shutterstock.com Readers are generally aware that scientific advancements are making it more possible to understand the genetic information inside each individual. It’s clear that the industry represents a massive opportunity. It’s fair
0 Comments
Known as a silicon-wafer fabricator or “fab,” Taiwan Semiconductor (NYSE:TSM) struggled along with other tech part makers amid 2021’s global supply shortage. Consequently, TSM stock chopped around and made little progress that year. Source: Sundry Photography / Shutterstock.com Now however, Wall Street is warming up to Taiwan Semiconductor in 2022. This company is rarely buzz-worthy in
0 Comments
When Tilray (NASDAQ:TLRY) posted a small profit in the last quarter, it marked a positive turning point. Skittish investors will ignore TLRY stock because of its meme trade last year sending it to a $67 high. Source: Ralf Liebhold / Shutterstock.com Those who avoided the quick pump (momentum buying) and fast dump (panic selling) should
0 Comments
Novavax (NASDAQ:NVAX) stock has been an under-performer among stocks that have been in the Covid-19 vaccine race. After touching highs of $331.7 in February 2021, NVAX stock has plunged to its current price levels of $90. Source: Vladimka production / Shutterstock.com Of course, there have been fundamental factors that have served as catalysts for the
0 Comments
Palantir (NYSE:PLTR) stock took a beating last year. PLTR stock is down more than 67% from its 52-week high price, currently sitting at $14.56. The signs of deceleration in the company’s public-sector business have been a key reason for the sluggishness. However, the positive developments in the past few months reiterate my belief in the
0 Comments
As young growth stock, SoFi Technologies (NASDAQ:SOFI) has had a few difficult weeks. SOFI stock dropped to nearly $12 on Jan. 18. It’s down  and is down more than 21% in the past six months. Source: Tada Images / Shutterstock.com The stock market sell-off has been very difficult for companies, but it is important to look
0 Comments
After an exceptional run last year, can Google’s parent company Alphabet’s (NASDAQ:GOOG, NASDAQ:GOOGL) stock again outperform its big tech peers and the broader market? Source: turbaliska / Shutterstock.com It’s a fair question to ask given that GOOGL stock has risen about 60% in the past 12-months to now trade at $2,771.74. Among large capitalization tech
0 Comments